CDI’s Perlin wins $33M grant to develop new antibiotics, as bacteria increasingly grow resistant to treatment

More than two million people are sickened every year in the U.S. with antibiotic-resistant infections, resulting in at least 23,000 deaths, according to the federal Centers for Disease Control and Prevention. One of the heads of the Center for Discovery and Innovation at Hackensack Meridian Health will get a chance to change that. Dr. David Perlin, the chief scientific officer of CDI, was awarded a $33.3 million grant by the National Institutes of Health to develop new antibiotics to overcome deadly bacteria in hospitals that have become resistant to current treatments, officials announced last week. (The story was also featured by NJBIZ.)

READ FULL ARTICLE ON ROI-NJ.COM